Literature DB >> 8222181

Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart.

I Wilson1, A M Gillinov, W E Curtis, J DiNatale, R M Burch, T J Gardner, D E Cameron.   

Abstract

BACKGROUND: Reduction of the leukocyte population during postischemic coronary reperfusion results in decreased neutrophil-mediated tissue injury. However, the importance of leukocyte adhesion to coronary endothelium for postischemic ventricular dysfunction after global hypothermic myocardial ischemia is unknown. Neutrophil integrins (CD11b/CD18) upregulate in response to cardiopulmonary bypass and ischemic stress, and their role in generating postoperative ventricular dysfunction was examined in this study. METHODS AND
RESULTS: An in vivo, in situ model of neonatal cardiac surgery was established in which neutrophil adherence was manipulated by administering NPC 15669 (an inhibitor of neutrophil CD11b/CD18 surface receptor upregulation). Seventeen 3- to 5-day-old piglets (8 controls and 9 NPC 15669-treated animals) were instrumented with a coronary sinus catheter, sonomicrometry crystals across the short axis of the left ventricle (LV), and a micromanometer positioned in the LV. Hearts were subjected to 90 minutes of hypothermic ischemia after a single dose of cold crystalloid cardioplegia. Myocardial granulocyte accumulation during ischemia and reperfusion was reduced in NPC animals compared with controls (myeloperoxidase activity, 43.4 +/- 2.6 and 75.8 +/- 6.3 mumol/10 mg tissue, respectively; P < or = .005). This was associated with a reduction in coronary vascular resistance in NPC animals compared with controls (P < or = .02) and decreased release of myocardial creatine phosphokinase throughout reperfusion (P < or = .05). NPC animals demonstrated an improved preservation of the end-systolic pressure-volume relation after discontinuation of cardiopulmonary bypass (71 +/- 6% and 96 +/- 6% at 60 minutes, respectively; P < or = .05). There was no difference in ventricular compliance between groups.
CONCLUSIONS: These data demonstrate that inhibition of neutrophil CD11b/CD18 surface adherence receptor upregulation reduces granulocyte accumulation in myocardium after hypothermic global ischemia, reduces myocyte damage, and improves ventricular systolic function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8222181

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  A simple, no-wash cell adhesion-based high-throughput assay for the discovery of small-molecule regulators of the integrin CD11b/CD18.

Authors:  Jun Y Park; M Amin Arnaout; Vineet Gupta
Journal:  J Biomol Screen       Date:  2007-04

Review 2.  New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

Authors:  Wendy Weston; Vineet Gupta; Rebecca Adkins; Roland Jurecic
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Agonist leukadherin-1 increases CD11b/CD18-dependent adhesion via membrane tethers.

Authors:  Emrah Celik; Mohd Hafeez Faridi; Vinay Kumar; Shashank Deep; Vincent T Moy; Vineet Gupta
Journal:  Biophys J       Date:  2013-12-03       Impact factor: 4.033

4.  Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease.

Authors:  Dony Maiguel; Mohd Hafeez Faridi; Changli Wei; Yoshihiro Kuwano; Keir M Balla; Dayami Hernandez; Constantinos J Barth; Geanncarlo Lugo; Mary Donnelly; Ali Nayer; Luis F Moita; Stephan Schürer; David Traver; Phillip Ruiz; Roberto I Vazquez-Padron; Klaus Ley; Jochen Reiser; Vineet Gupta
Journal:  Sci Signal       Date:  2011-09-06       Impact factor: 8.192

5.  Extracorporeal membrane oxygenation induced cardiac dysfunction in newborn lambs.

Authors:  Lee A Pyles; Robert A Gustafson; James Fortney; Stanley Einzig
Journal:  J Cardiovasc Transl Res       Date:  2010-09-17       Impact factor: 4.132

6.  A Small Molecule β2 Integrin Agonist Improves Chronic Kidney Allograft Survival by Reducing Leukocyte Recruitment and Accompanying Vasculopathy.

Authors:  Samia Q Khan; Lingling Guo; David J Cimbaluk; Hatem Elshabrawy; Mohd Hafeez Faridi; Meenakshi Jolly; James F George; Anupam Agarwal; Vineet Gupta
Journal:  Front Med (Lausanne)       Date:  2014-11-12

7.  Docosahexaenoic Acid Inhibits Vascular Smooth Muscle Cell Proliferation Induced by Glucose Variability.

Authors:  Kaliyaperumal Rani; Nway Y Aung
Journal:  Open Biochem J       Date:  2017-06-30

Review 8.  GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors.

Authors:  David G DeNardo; Anna Galkin; Jakob Dupont; Lei Zhou; Johanna Bendell
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.